We selected a CEM T cell line model due to its relevance in immune response, viral infection, and cancers, such as T- and B-cell malignancies, for which the HDAC inhibitor drugs, vorinostat and romidepsin, are currently being employed for treatment. This evidence concerns the gene HDAC9 and cancer.